Mineralys Therapeutics, Inc. (MLYS)
25.40
-0.27
(-1.05%)
USD |
NASDAQ |
Sep 01, 10:10
Mineralys Therapeutics Cash and Short Term Investments (Quarterly) : 661.41M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 661.41M |
| March 31, 2026 | 646.06M |
| December 31, 2025 | 656.64M |
| September 30, 2025 | 593.63M |
| June 30, 2025 | 324.92M |
| March 31, 2025 | 343.03M |
| December 31, 2024 | 198.19M |
| September 30, 2024 | 263.60M |
| June 30, 2024 | 311.12M |
| March 31, 2024 | 338.56M |
| Date | Value |
|---|---|
| December 31, 2023 | 236.57M |
| September 30, 2023 | 253.76M |
| June 30, 2023 | 261.10M |
| March 31, 2023 | 270.64M |
| December 31, 2022 | 110.11M |
| September 30, 2022 | 120.95M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 10.66M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| MapLight Therapeutics, Inc. | 304.72M |
| Evommune, Inc. | 200.79M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |